SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-22-008260
Filing Date
2022-02-17
Accepted
2022-02-17 16:19:13
Documents
1
Group Members
YI SHI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea155205-13glav_tempest.htm SC 13G 66889
  Complete submission text file 0001213900-22-008260.txt   68677
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87213 | Film No.: 22648361
SIC: 2834 Pharmaceutical Preparations

Mailing Address UNIT 902-904, TWO CHINACHEM CENTRAL 26 DES VOEUX ROAD, CENTRAL HONG KONG K3 00000
Business Address UNIT 902-904, TWO CHINACHEM CENTRAL 26 DES VOEUX ROAD, CENTRAL HONG KONG K3 00000 650-665-7822
LAV Regulus Ltd (Filed by) CIK: 0001912044 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G